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Dis definitely faster in patients with functional or ischemic mitral
regurgitation, and I think that has to do with concomitant right
ventricular dysfunction in those patients versus a patient with
mitral valve prolapse. But you are still going to have to create
a study that spans many years, as well as choose an appropriate
clinical end point. Unfortunately, in my opinion New York Heart
Association functional class is a poor metric for right heart
function. I did not have data on diuretic use, liver transaminases,
or kidney function. I believe that in a clinical trial a surrogate end
point, such as right ventricular dimensions or function in addition
to grade of tricuspid regurgitation, would need to be used.
However I definitely agree that a randomized prospective trial
would be ideal to help inform the cardiac surgery community on
this controversial issue.
Dr Harold L. Lazar (Boston, Mass). Did you measure
pulmonary artery (PA) pressures either by echo or by cath and
have you found that to be a determinant of what ultimately happensEDITORIAL CO
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2810 The Journal of Thoracic and Cardiovascular Surto the TR? I have seen that patients who have minimal TR but have
high PA pressures at the time of mitral valve replacement or
repair tend to be the ones who tend to have increased TR in the
future.
Dr Goldstone. We did look at PA pressures. They were
measured by right heart catheterization, and preoperative mean
PA pressure was not a significant predictor of progression of TR
postoperatively in univariate analysis. That is consistent with the
Mayo paper, which did not find pulmonary artery pressure to be
a significant predictor either. I agree that it makes sense that
pulmonary hypertension would influence TR progression.
Perhaps the reason why different studies identify different
predictors of TR progression alludes to the multifactorial nature
of functional TR.
Dr Lazar. In those patients who had progressive TR, did their
PA pressures go up or did they stay the same?
Dr Goldstone. I do not have longitudinal data on PA pressure.MMENTARYThe role of cognitive dissonance in the management of functional
tricuspid regurgitation at the time of degenerative mitral valve repairRakesh M. Suri, MD, DPhil,a and Yan Topilsky, MDbCognitive dissonance: Psychologic conflict resulting
from incongruous beliefs and attitudes held
simultaneously.
In this issue of the Journal, Goldstone and colleagues1
from the University of Pennsylvania and Stanford have
assembled the third largest series (n¼ 495) in the literature
of patients with mitral valve prolapse undergoing mitral
valve repair with coexistent functional tricuspid valve
regurgitation (TR) not surgically managed. Forty-three
percent of patients had anywhere between trivial to
moderately severe TR at mitral valve repair, and freedomfrom greater than moderate TR was approximately 60%
at 9 years. Older age and grade of preoperative TR pre-
dicted progression; and ‘‘some degree’’ of right ventricular
dysfunction was more frequent in those with severe TR
during follow-up.
What does this study tell us? The findings reaffirm those
published from the Mayo Clinic in 2011 and in 2014.2,3 Our
institution’s first series studied 699 patients who underwent
mitral valve repair for isolated degenerative leaflet prolapse
and moderate or less coexistent functional TR. We
identified that moderate TR actually regressed with time
in most cases after successful and durable repair of
degenerative mitral valve disease. Indeed, only 1 patient
out of the entire series required reoperation for
progressive TR 4.5 years after mitral valve repair. Our
most recent report expanded on this analysis, studying
747 adult patients with mitral valve prolapse among
whom 683 underwent mitral valve repair and 64 had
replacement. We found no difference in the occurrence of
moderately severe or severe TR after mitral valve repair
versus replacement and found the univariate predictors of
TR progression to be older age, female sex, higher
pulmonary arterial pressure, and larger left atrial size.
Only 2 patients required reoperation for late functional
TR. The report of Goldstone and colleagues1 thus adds togery c December 2014
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FIGURE 1. Kaplan-Meier estimates of the rates of cardiovascular events
in patients with normal ejection fraction, normal pulmonary pressure, and
no other significant comorbidity stratified by tricuspid regurgitation
severity. Values in parentheses are event rates at 5 years, which differed
significantly between patients with moderate tricuspid regurgitation (TR;
effective regurgitant orifice [ERO]<40 mm2) and severe tricuspid regurgi-
tation (effective regurgitant orifice>40 mm2) but not between patients




Dan already significant body of evidence in existence reassur-
ing us that the performance of early correction of mitral
regurgitation is important not only for its own well-known
benefits4 (preservation of survival and minimization of
late heart failure risk) but also to diminish the late occur-
rence of functional TR.
Although the data of Goldstone and colleagues1 are
entirely consistent with our own, their conclusions are incon-
gruous and puzzling in stating that ‘‘less than severe TR is
likely to progress after surgery if uncorrected.’’ They use
‘‘RV [right ventricular] dysfunction’’ to justify concomitant
tricuspid valve repair, even though symptoms, survival, and
reoperation were not affected by TR according to their own
data. Unfortunately, the fatal flaw lies in reliance on semi-
quantitative assessments of right ventricular function, which
undermines the validity of the intended conclusion. Qualita-
tive assessment of RV size and function is no longer recom-
mended by current guidelines5 because it is associated with
wide interreader variability.6 Importantly, in the presence of
TR,RVafterload decreases and right atrial pressure increases,
making qualitative assessment of RV function even more
inaccurate.
Although the specter of an at times high-risk reoper-
ation for progressive TR in the setting of severe mitral
regurgitation caused by ischemic disease, rheumatic
valvulopathy, congenital heat disease, or radiation heart
disease no doubt merits careful avoidance, all available
scientific evidence has proved this to be a very low
likelihood event in the setting of degenerative mitral
valve disease. We recently have shown that lesser de-
grees of quantified TR are in fact associated withThe Journal of Thoracic and Carneither excess mortality (Figure 1) nor excess morbidity
in the context of normal ejection fraction, normal
pulmonary pressure, and absence of significant comor-
bidities.7 Reassuringly, patients with incidentally discov-
ered less than moderate functional TR undergoing early
degenerative mitral valve repair are most likely to fulfil
these low risk criteria. Although the article of Gold-
stone and colleagues1 proposes that, by default,
concomitant tricuspid repair ‘‘may be warranted,’’
tricuspid valve repair was not, in fact, studied in the
current report at all, and thus this extrapolated and
nuanced conclusion reaches beyond the scope of the
presented data.
On the basis of available long-term outcomes data, the
psychologic stress of not intervening upon the tricuspid
valve should therefore be diminished when specifically
considering patients with mitral valve prolapse, particularly
those undergoing early mitral repair before the onset
of guideline-based triggers (such as symptoms, ejection
fraction <60%, left ventricular end-systolic diameter
>40 mm, pulmonary pressure >50 mm Hg, or atrial
fibrillation). Proponents of routine concomitant TR repair
often ask, ‘‘What could be simpler, snare the venae cavae,
open the right atrium, and place a cerclage stitch or
annuloplasty band?’’ Although as surgeons we may find
this technically appealing and philosophically satisfying,
the simple fact remains that the weight of evidence does
not support this practice in all settings. Rationally, the
performance of concomitant tricuspid repair at the time of
degenerative mitral valve repair should be strongly consid-
ered in the presence of (1) greater than moderate TR, (2)
right heart dysfunction or right heart failure symptoms,
(3) pulmonary hypertension, (4) reduced left ventricular
systolic function or cardiomyopathy, and (5) organic
tricuspid valve pathology. In contrast, the decision to pursue
conservative management of less than moderate functional
TR in patients who undergo effective degenerative mitral
regurgitation correction and who are unlikely ever to have
difficulty with the tricuspid valve or the right ventricle
should not engender cognitive dissonance due to the fact
that it is congruous with all currently available scientific
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